Glucose-lowering Effect Over 24 Hours In Patients With Type 1 Diabetes (Image 01)
Insulin Glargine Injection, Solution
Product Images NDC 83257-014
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Insulin Glargine (NDC 83257-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biocon Biologics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Step 1 (Image 02)
Step 2 (Image 03)
Step 3 (Image 04)
Step 4 (Image 05)
Step 5 (Image 06)
Step 7 (Image 07)
Step 8 (Image 08)
Places To Inject (Image 09)
Upper arms: This refers to the area of the arms above the elbows. It includes the biceps and triceps muscles and is a common target for exercise and muscle development.
Front and side of thigh: This refers to the areas of the leg that are located at the front and side, specifically the quadriceps muscles in the front and the hamstrings and adductors on the sides. These muscle groups are important for leg strength and stability.*
Get To Know Your Pen (Image 10)
This document appears to be describing a pen cartridge pen used for injections. It includes information about the expiration date, dose measurement, and injection process. The pen features a cap holder, body, pointer, and button for administering the dose. There is also a rubber seal and a window selector for selecting the desired insulin dose. Please note that the pen needle is not included.*
Figure A (Image 11)
Figure B (Image 12)
Figure C (Image 13)
Figure D (Image 14)
Figure E (Image 15)
Figure F (Image 16)
Figure G (Image 17)
Figure H (Image 18)
Figure I (Image 19)
Figure J (Image 20)
Figure K (Image 21)
Figure L (Image 22)
Figure M (Image 23)
Figure N (Image 24)
Figure O (Image 25)
Figure P (Image 26)
Figure Q (Image 27)
Figure R (Image 28)
Figure S (Image 29)
Figure T (Image 30)
Figure U (Image 31)
Figure V (Image 32)
Insulin Glargine-yfgn Injection, 100 Units/ml (u-100) (Pen)
Insulin Glargine-yfgn Injection, 100 Units/ml (u-100) (Vial)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
